217 related articles for article (PubMed ID: 15920699)
1. The gene expression profile of extraskeletal myxoid chondrosarcoma.
Subramanian S; West RB; Marinelli RJ; Nielsen TO; Rubin BP; Goldblum JR; Patel RM; Zhu S; Montgomery K; Ng TL; Corless CL; Heinrich MC; van de Rijn M
J Pathol; 2005 Aug; 206(4):433-44. PubMed ID: 15920699
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence in situ hybridization analysis of extraskeletal myxoid chondrosarcomas using EWSR1 and NR4A3 probes.
Noguchi H; Mitsuhashi T; Seki K; Tochigi N; Tsuji M; Shimoda T; Hasegawa T
Hum Pathol; 2010 Mar; 41(3):336-42. PubMed ID: 19775727
[TBL] [Abstract][Full Text] [Related]
3. cDNA expression profiling of chondrosarcomas: Ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing grade.
Rozeman LB; Hameetman L; van Wezel T; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
J Pathol; 2005 Sep; 207(1):61-71. PubMed ID: 16007578
[TBL] [Abstract][Full Text] [Related]
4. Cytopathology of extraskeletal myxoid chondrosarcoma: report of 8 cases.
Jakowski JD; Wakely PE
Cancer; 2007 Oct; 111(5):298-305. PubMed ID: 17676582
[TBL] [Abstract][Full Text] [Related]
5. Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 18 cases.
Okamoto S; Hisaoka M; Ishida T; Imamura T; Kanda H; Shimajiri S; Hashimoto H
Hum Pathol; 2001 Oct; 32(10):1116-24. PubMed ID: 11679947
[TBL] [Abstract][Full Text] [Related]
6. t(9;22)(q22-31;q11-12) is a consistent marker of extraskeletal myxoid chondrosarcoma: evaluation of three cases.
Sciot R; Dal Cin P; Fletcher C; Samson I; Smith M; De Vos R; Van Damme B; Van den Berghe H
Mod Pathol; 1995 Sep; 8(7):765-8. PubMed ID: 8539235
[TBL] [Abstract][Full Text] [Related]
7. Extraskeletal myxoid chondrosarcoma: updated clinicopathological and molecular genetic characteristics.
Hisaoka M; Hashimoto H
Pathol Int; 2005 Aug; 55(8):453-63. PubMed ID: 15998372
[TBL] [Abstract][Full Text] [Related]
8. A novel sarcoma with dual differentiation: clinicopathologic and molecular characterization of a combined synovial sarcoma and extraskeletal myxoid chondrosarcoma.
Vergara-Lluri ME; Stohr BA; Puligandla B; Brenholz P; Horvai AE
Am J Surg Pathol; 2012 Jul; 36(7):1093-8. PubMed ID: 22743288
[TBL] [Abstract][Full Text] [Related]
9. Extraskeletal myxoid chondrosarcoma of the jugular foramen.
Cummings TJ; Bridge JA; Fukushima T
Clin Neuropathol; 2004; 23(5):232-7. PubMed ID: 15581026
[TBL] [Abstract][Full Text] [Related]
10. Osseous myxochondroid sarcoma: a detailed study of 5 cases of extraskeletal myxoid chondrosarcoma of the bone.
Demicco EG; Wang WL; Madewell JE; Huang D; Bui MM; Bridge JA; Meis JM
Am J Surg Pathol; 2013 May; 37(5):752-62. PubMed ID: 23588370
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma.
Panagopoulos I; Mertens F; Isaksson M; Domanski HA; Brosjö O; Heim S; Bjerkehagen B; Sciot R; Dal Cin P; Fletcher JA; Fletcher CD; Mandahl N
Genes Chromosomes Cancer; 2002 Dec; 35(4):340-52. PubMed ID: 12378528
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
[TBL] [Abstract][Full Text] [Related]
13. Microtubule-associated protein-2 and class III beta-tubulin are expressed in extraskeletal myxoid chondrosarcoma.
Hisaoka M; Okamoto S; Koyama S; Ishida T; Imamura T; Kanda H; Kameya T; Meis-Kindblom JM; Kindblom LG; Hashimoto H
Mod Pathol; 2003 May; 16(5):453-9. PubMed ID: 12748252
[TBL] [Abstract][Full Text] [Related]
14. The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene.
Filion C; Motoi T; Olshen AB; Laé M; Emnett RJ; Gutmann DH; Perry A; Ladanyi M; Labelle Y
J Pathol; 2009 Jan; 217(1):83-93. PubMed ID: 18855877
[TBL] [Abstract][Full Text] [Related]
15. Studies on the molecular pathogenesis of extraskeletal myxoid chondrosarcoma-cytogenetic, molecular genetic, and cDNA microarray analyses.
Sjögren H; Meis-Kindblom JM; Orndal C; Bergh P; Ptaszynski K; Aman P; Kindblom LG; Stenman G
Am J Pathol; 2003 Mar; 162(3):781-92. PubMed ID: 12598313
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of cytomorphological features, including literature review, of an extraskeletal myxoid chondrosarcoma with t(9;22)(q22;q12) (TEC/EWS) results in one case.
Kumar R; Rekhi B; Shirazi N; Pais A; Amare P; Gawde D; Jambhekar N
Diagn Cytopathol; 2008 Dec; 36(12):868-75. PubMed ID: 18925568
[TBL] [Abstract][Full Text] [Related]
17. Skeletal and extraskeletal myxoid chondrosarcoma: a comparative clinicopathologic, ultrastructural, and molecular study.
Antonescu CR; Argani P; Erlandson RA; Healey JH; Ladanyi M; Huvos AG
Cancer; 1998 Oct; 83(8):1504-21. PubMed ID: 9781944
[TBL] [Abstract][Full Text] [Related]
18. TFG is a novel fusion partner of NOR1 in extraskeletal myxoid chondrosarcoma.
Hisaoka M; Ishida T; Imamura T; Hashimoto H
Genes Chromosomes Cancer; 2004 Aug; 40(4):325-8. PubMed ID: 15188455
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets.
Capurso G; Lattimore S; Crnogorac-Jurcevic T; Panzuto F; Milione M; Bhakta V; Campanini N; Swift SM; Bordi C; Delle Fave G; Lemoine NR
Endocr Relat Cancer; 2006 Jun; 13(2):541-58. PubMed ID: 16728581
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of NOR1 and SIX3 proteins in extraskeletal myxoid chondrosarcomas without detectable NR4A3 fusion genes.
Hisaoka M; Okamoto S; Yokoyama K; Hashimoto H
Cancer Genet Cytogenet; 2004 Jul; 152(2):101-7. PubMed ID: 15262426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]